These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 16962750)

  • 1. Studies on dissolution enhancement and mathematical modeling of drug release of a poorly water-soluble drug using water-soluble carriers.
    Ahuja N; Katare OP; Singh B
    Eur J Pharm Biopharm; 2007 Jan; 65(1):26-38. PubMed ID: 16962750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In sight into tadalafil - block copolymer binary solid dispersion: Mechanistic investigation of dissolution enhancement.
    Mehanna MM; Motawaa AM; Samaha MW
    Int J Pharm; 2010 Dec; 402(1-2):78-88. PubMed ID: 20933589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.
    Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A
    Colloids Surf B Biointerfaces; 2010 Mar; 76(1):170-8. PubMed ID: 19945828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P; Lee PI
    Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution behaviour of nalidixic acid solid dispersions using water soluble dispersion carriers.
    Mallick S; Sahu A; Pal K
    Acta Pol Pharm; 2004; 61(1):21-30. PubMed ID: 15259854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution rate enhancement of the poorly water-soluble drug Tibolone using PVP, SiO2, and their nanocomposites as appropriate drug carriers.
    Papadimitriou S; Bikiaris D
    Drug Dev Ind Pharm; 2009 Sep; 35(9):1128-38. PubMed ID: 19555245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and characterization of gliclazide-polyethylene glycol 4000 solid dispersions.
    Patil MP; Gaikwad NJ
    Acta Pharm; 2009 Mar; 59(1):57-65. PubMed ID: 19304558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
    Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
    Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improving the solubility of ampelopsin by solid dispersions and inclusion complexes.
    Ruan LP; Yu BY; Fu GM; Zhu DN
    J Pharm Biomed Anal; 2005 Jul; 38(3):457-64. PubMed ID: 15925247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and optimization of mouth dissolve tablets containing rofecoxib solid dispersion.
    Sammour OA; Hammad MA; Megrab NA; Zidan AS
    AAPS PharmSciTech; 2006 Jun; 7(2):E55. PubMed ID: 16796372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407.
    Newa M; Bhandari KH; Oh DH; Kim YR; Sung JH; Kim JO; Woo JS; Choi HG; Yong CS
    Arch Pharm Res; 2008 Nov; 31(11):1497-507. PubMed ID: 19023548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of rofecoxib-polyethylene glycol 4000 solid dispersions and tablets based on solid dispersions.
    Liu C; Desai KG
    Pharm Dev Technol; 2005; 10(4):467-77. PubMed ID: 16370176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation, characterization, and dissolution studies of ibuprofen solid dispersions using polyethylene glycol (PEG), talc, and PEG-talc as dispersion carriers.
    Khan GM; Jiabi Z
    Drug Dev Ind Pharm; 1998 May; 24(5):455-62. PubMed ID: 9876608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S; Ortega M; Ma C
    Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraorally fast-dissolving particles of a poorly soluble drug: preparation and in vitro characterization.
    Laitinen R; Suihko E; Toukola K; Björkqvist M; Riikonen J; Lehto VP; Järvinen K; Ketolainen J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):271-81. PubMed ID: 18824096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raman and thermal analysis of indomethacin/PVP solid dispersion enteric microparticles.
    Fini A; Cavallari C; Ospitali F
    Eur J Pharm Biopharm; 2008 Sep; 70(1):409-20. PubMed ID: 18621516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solubility and dissolution improvement of Rofecoxib using solid dispersion technique.
    Rahamathulla M; Hv G; Rathod N
    Pak J Pharm Sci; 2008 Oct; 21(4):350-5. PubMed ID: 18930854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and physicochemical characterizations of tanshinone IIA solid dispersion.
    Zhao X; Liu X; Gan L; Zhou C; Mo J
    Arch Pharm Res; 2011 Jun; 34(6):949-59. PubMed ID: 21725816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method.
    Zajc N; Obreza A; Bele M; Srcic S
    Int J Pharm; 2005 Mar; 291(1-2):51-8. PubMed ID: 15707731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing the bioavailability of ABT-963 using solid dispersion containing Pluronic F-68.
    Chen Y; Zhang GG; Neilly J; Marsh K; Mawhinney D; Sanzgiri YD
    Int J Pharm; 2004 Nov; 286(1-2):69-80. PubMed ID: 15501003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.